Skip to main
TDOC

Teladoc (TDOC) Stock Forecast & Price Target

Teladoc (TDOC) Analyst Ratings

Based on 14 analyst ratings
Buy
Strong Buy 21%
Buy 14%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Teladoc Health is well-positioned to capitalize on the growing trend towards virtual healthcare services, especially in light of its strong performance during the Covid-19 pandemic. The company's integrated care segment, which offers virtual primary care, mental health, and chronic care management services, is expected to generate significant revenue and contribute to overall growth. Additionally, the company's BetterHelp platform, which provides direct-to-consumer online mental health services, continues to gain traction and expand into new markets. Teladoc's strong cost management and investment in cutting-edge technology, such as its 24/7 care offering and AI capabilities, should further bolster its competitiveness in the market. While there are potential headwinds, such as competition and uncertainties surrounding the future of BetterHelp, overall, Teladoc Health is positioned for continued success and growth in the virtual healthcare industry.

Bears say

Teladoc Health is facing multiple challenges that could significantly impact its financial performance in the coming years. These challenges include low revenue growth and model uncertainties due to a shift from stable subscription revenue to a more volatile visit-based model, potential membership declines, and fierce competition in all of its markets. The company's inability to evolve its value propositions and establish pricing power could result in significant gross margin pressures in the future. However, the company still has potential for growth in the emerging primary care market, but this potential may be limited due to constraints on its capacity to respond to market dynamics and its focus on cost-cutting measures over growth. In light of these challenges, it is crucial for Teladoc Health to execute its current strategies effectively in order to maintain its position as a market leader and improve its financial performance.

Teladoc (TDOC) has been analyzed by 14 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 14% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Teladoc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Teladoc (TDOC) Forecast

Analysts have given Teladoc (TDOC) a Buy based on their latest research and market trends.

According to 14 analysts, Teladoc (TDOC) has a Buy consensus rating as of Aug 14, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $7.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $7.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Teladoc (TDOC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.